Read Interim President Jeff Ettinger's statement on Walz-Flanagan Administration’s infrastructure plan and bonding proposal ahead of the 2024 legislative session.
The Center for Animal Health and Food Safety (CAHFS) at the University of Minnesota’s College of Veterinary Medicine has been awarded a seven-year, $4.99 million grant from the Bill & Melinda Gates Foundation to support veterinary services capacity-building in East Africa. The grant aims to specifically build capacity for the critical evaluation, evidence-based revision and long-term monitoring of disease control programs to support local systems of animal health and food safety through group training and workforce development.
U of M and Mayo Clinic researchers have been awarded $6.75 million to fund innovative projects on cancer, rare genetic diseases, neurodegenerative diseases, cognitive aging and new health models to study diseases.
During its December 2023 meeting, the Board of Regents discussed the University’s many strategic successes and key accountability measures across its five campuses.
The Board of Regents will review the state of the University’s billion-dollar research and technology commercialization enterprises as part of its December 2023 meetings.
The study is the first to examine rotary instrumentation splatter created during oral surgery procedures, and its findings provide several key suggestions for the future of oral surgery.
Today, the University of Minnesota School of Public Health is announcing the launch of a new Cannabis Research Center (CRC) in order to track the impact of adult-use marijuana and help inform future cannabis policies and practices across the state of Minnesota.
Recent technological advances have enabled the production of vast amounts of data types that can help health researchers better understand complex diseases, such as cancer, cardiovascular diseases and neurodegenerative disorders.
Researchers analyzed data from approximately 50% of all registered medical cannabis users in Minnesota between June 2016 and November 2019 to characterize the extent of their exposure to cannabis products.
For more than 30 years, section 340B of the Public Health Service Act has required drug manufacturers to sell outpatient drugs at discounted prices to certain safety-net hospitals and health care organizations that serve uninsured or low-income patients. 340B-eligible health care providers (called “covered entities”) contract with pharmacies to dispense the discounted drugs — a mutually beneficial relationship that increases revenue for providers and pharmacies. Today, about 40% of retail pharmacies across the country have at least one contract with a 340B-eligible health care provider.
Minnesota MedTech 3.0 emerged from a strong field of roughly 200 proposals around the country to earn one of 31 designations announced today, designations that will open new opportunities for federal support to accelerate innovation and discovery.
During its October 2023 meetings, the Board of Regents approved state requests for facility renewal and recurring operational funding to match current year levels.
